Natural Biocon (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 ,inter alia, to consider and approve Unaudited financial ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Natural Biocon (India) Ltd has informed BSE that its Board of Directors will meet on Friday, 13th February 2026 at the registered office. The main agenda is to consider and approve the unaudited financial results for the third quarter ended 31st December 2025, along with the auditor's limited review report. Any other business item may be taken up with the Chairman's permission. The filing is made under Regulation 29 of SEBI's Listing Obligations and Disclosure Requirements Regulations, 2015.
This is a routine pre-results intimation and does not by itself move the stock. Investors should watch for the actual Q3 numbers on or after 13th February 2026 to assess the company's performance and any outlook commentary.